The Patient with Asthma in the Emergency Department



Patients of all ages present to the emergency department (ED) with respiratory ­distress and wheezing. Initial evaluation entails assessing the severity of the respiratory distress and determining if an acute exacerbation of asthma is the cause.


Emergency Department Acute Exacerbation Asthma Exacerbation Acute Asthma Peak Expiratory Flow Rate 


  1. 1.
    Moorman JE, Rudd RA, Johnson CA, King M, Minor P, Bailey C, et al. National surveillance for asthma—United States, 1980–2004. MMWR Surveill Summ. 2007;56(8):1–54.PubMedGoogle Scholar
  2. 2.
    Aaron SD, Vandemheen KL, Boulet LP, McIvor RA, Fitzgerald JM, Hernandez P, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ. 2008;179(11):1121–31.PubMedCrossRefGoogle Scholar
  3. 3.
    Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007;120(5 Suppl):S94–138.Google Scholar
  4. 4.
    Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, Fitzgerald JM. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1804–9.Google Scholar
  5. 5.
    Rea HH, Garrett JE, Lanes SF, Birmann BM, Kolbe J. The association between asthma drugs and severe life-threatening attacks. Chest. 1996;110(6):1446–51.PubMedCrossRefGoogle Scholar
  6. 6.
    Kramer JM. Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values. N Engl J Med. 2009;360(16):1592–5.PubMedCrossRefGoogle Scholar
  7. 7.
    van Belle A, Buller HR, Huisman MV, Huisman PM, Kaasjager K, Kamphuisen PW, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA. 2006;295(2):172–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2006(2):CD000052.Google Scholar
  9. 9.
    Page CP, Morley J. Contrasting properties of albuterol stereoisomers. J Allergy Clin Immunol. 1999;104(2 Pt 2):S31-41.PubMedCrossRefGoogle Scholar
  10. 10.
    Kelly HW. Levalbuterol for asthma: a better treatment? Curr Allergy Asthma Rep. 2007;7(4):310–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Rowe BH, Edmonds ML, Spooner CH, Diner B, Camargo CA, Jr. Corticosteroid therapy for acute asthma. Respir Med. 2004;98(4):275–84.PubMedCrossRefGoogle Scholar
  12. 12.
    Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2001(1):CD002178.Google Scholar
  13. 13.
    Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev. 2000(2):CD000195.Google Scholar
  14. 14.
    Emerman CL, Cydulka RK. A randomized comparison of 100-mg vs 500-mg dose of methylprednisolone in the treatment of acute asthma. Chest. 1995;107(6):1559–63.PubMedCrossRefGoogle Scholar
  15. 15.
    Manser R, Reid D, Abramson M. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev. 2001(1):CD001740.Google Scholar
  16. 16.
    Lahn M, Bijur P, Gallagher EJ. Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest. 2004;126(2):362–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Krishnan JA, Davis SQ, Naureckas ET, Gibson P, Rowe BH. An umbrella review: corticosteroid therapy for adults with acute asthma. Am J Med. 2009;122(11):977–91.PubMedCrossRefGoogle Scholar
  18. 18.
    Camargo CA, Jr., Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev. 2003(4):CD001115.Google Scholar
  19. 19.
    Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax. 2005;60(9):740–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Mohammed S, Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis. Emerg Med J. 2007;24(12):823–30.PubMedCrossRefGoogle Scholar
  21. 21.
    Rowe BH, Camargo CA, Jr. The role of magnesium sulfate in the acute and chronic management of asthma. Curr Opin Pulm Med. 2008;14(1):70–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Lazarus SC. Clinical practice. Emergency treatment of asthma. N Engl J Med. 2010;363(8):755–64.Google Scholar
  23. 23.
    Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev. 2006(4):CD002884.Google Scholar
  24. 24.
    Shapiro JM. Intensive care management of status asthmaticus. Chest. 2001;120(5):1439–41.PubMedCrossRefGoogle Scholar
  25. 25.
    Cheong B, Reynolds SR, Rajan G, Ward MJ. Intravenous beta agonist in severe acute asthma. BMJ. 1988;297(6646):448–50.PubMedCrossRefGoogle Scholar
  26. 26.
    Salmeron S, Brochard L, Mal H, Tenaillon A, Henry-Amar M, Renon D, et al. Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. Am J Respir Crit Care Med. 1994;149(6):1466–70.PubMedGoogle Scholar
  27. 27.
    Travers AH, Rowe BH, Barker S, Jones A, Camargo CA, Jr. The effectiveness of IV beta-agonists in treating patients with acute asthma in the emergency department: a meta-analysis. Chest. 2002;122(4):1200–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev. 2000(4):CD002742.Google Scholar
  29. 29.
    Camargo CA, Jr., Gurner DM, Smithline HA, Chapela R, Fabbri LM, Green SA, et al. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol. 2010;125(2):374–80.PubMedCrossRefGoogle Scholar
  30. 30.
    Ramsay CF, Pearson D, Mildenhall S, Wilson AM. Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial. Thorax. 2010.Google Scholar
  31. 31.
    Aroni F, Iacovidou N, Dontas I, Pourzitaki C, Xanthos T. Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug. J Clin Pharmacol. 2009;49(8):957–64.PubMedCrossRefGoogle Scholar
  32. 32.
    Howton JC, Rose J, Duffy S, Zoltanski T, Levitt MA. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med. 1996;27(2):170–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med. 2005;46(1):43–50.PubMedCrossRefGoogle Scholar
  34. 34.
    Denmark TK, Crane HA, Brown L. Ketamine to avoid mechanical ventilation in severe pediatric asthma. J Emerg Med. 2006;30(2):163–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Caples SM, Gay PC. Noninvasive positive pressure ventilation in the intensive care unit: a concise review. Crit Care Med. 2005;33(11):2651–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Meduri GU, Cook TR, Turner RE, Cohen M, Leeper KV. Noninvasive positive pressure ventilation in status asthmaticus. Chest. 1996;110(3):767–74.PubMedCrossRefGoogle Scholar
  37. 37.
    Fernandez MM, Villagra A, Blanch L, Fernandez R. Non-invasive mechanical ventilation in status asthmaticus. Intensive Care Med. 2001;27(3):486–92.PubMedCrossRefGoogle Scholar
  38. 38.
    Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest. 2003;123(4):1018–25.PubMedCrossRefGoogle Scholar
  39. 39.
    Gupta D, Nath A, Agarwal R, Behera D. A prospective randomized controlled trial on the efficacy of noninvasive ventilation in severe acute asthma. Respir Care. 2010;55(5):536–43.PubMedGoogle Scholar
  40. 40.
    Behbehani NA, Al-Mane F, D’Yachkova Y, Pare P, FitzGerald JM. Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest. 1999;115(6):1627–31.PubMedCrossRefGoogle Scholar
  41. 41.
    Shrestha M, Bidadi K, Gourlay S, Hayes J. Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest. 1996;110(1):42–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for reversible airway disease. Cochrane Database Syst Rev. 2002(4):CD002992.Google Scholar
  43. 43.
    Mallmann F, Fernandes AK, Avila EM, Nogueira FL, Steinhorst AM, Saucedo DZ, et al. Early prediction of poor outcome in patients with acute asthma in the emergency room. Braz J Med Biol Res. 2002;35(1):39–47.PubMedCrossRefGoogle Scholar
  44. 44.
    Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003(1):CD001117.Google Scholar
  45. 45.
  46. 46.
    Leiner GC, Abramowitz S, Small MJ, Stenby VB, Lewis WA. Expiratory Peak Flow Rate. Standard Values for Normal Subjects. Use as a Clinical Test of Ventilatory Function. Am Rev Respir Dis. 1963;88:644–51.PubMedGoogle Scholar
  47. 47.
    McElroy S. Pediatric Emergency Medicine: The Essentials. Boston, MA: Health Emergency Publishing; 2004.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal MedicineUniversity of California at DavisDavisUSA
  2. 2.VA Northern California Health Care SystemMatherUSA
  3. 3.Department of Emergency MedicineUniversity of California at DavisSacramentoUSA

Personalised recommendations